10-K/A XBRL

AMENDED 10-K

Company: TherapeuticsMD, Inc.
Filed: April 29, 2020
Period of Report: December 31, 2019
Accession Number: 0001387131-20-004224

View Document ↗ View on SEC.gov ↗